Do we get to see the data that was released to the FDA about the vaccines? thx in advance

[MineralMan]

73. Your OP was based on the assumption that the data would not

be made available. It will, but it's not yet time for that.

Here's my prediction: Once it is made available, you will not examine that data.

There's still not a long-term plan for distribution of the vaccines yet. There will be one, though, and we'll all get to see it when it's ready. Until then, we can either speculate about how "unfair" it will be, or we can wait to see what it actually is.

The peer-reviewed papers on the various vaccines will appear first in professional journals, all of which will charge to to read it. Soon after that, though, science writers will summarize that data for public consumption.

Those summaries will be available to everyone. I recommend them as your source, frankly.

Disclaimer: Since I write about neuroscience research, I pay for access to journal sites, so I can read articles as they appear without paying for individual articles. It's not cheap, but I no longer have a University library connection that gives me free access. Will I go look at the first journal articles about these vaccines? I will not. I will wait for someone who specializes in summarizing such articles to write summaries. I could read the original journal articles, but that's a time-consuming thing.

There's no secrecy involved. There will be transparency, once the official data is put into publishable form. It's not yet in that form. Submissions have been made in the requests for emergency approval by the FDA, but those are specialized submissions. You will have access to much more than that before you have to decide whether to receive the vaccine or not. There's no secret plan to keep you from getting whatever information you think is sufficient.

You're just unhappy you don't have access to it now. Patience is a virtue. The processes that normally apply will all be followed. But, here's the kicker: What is released soon will only be the results of the Stage 3 trials, most of which were limited to about 30,000 subjects in a controlled trial.

The real trial will be measured by the data generated by a large-scale release of the vaccine. In some ways, we'll all be subjects of that trial, if we take the vaccine. Those who don't will be the control group. Your choice.